OTCMKTS:FSNUY Fresenius SE & Co. KGaA - FSNUY Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Fresenius SE & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. $6.46 +0.16 (+2.54%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$6.40▼$6.4650-Day Range$6.19▼$7.7552-Week Range$4.79▼$9.71Volume42,004 shsAverage Volume36,552 shsMarket Capitalization$14.43 billionP/E Ratio9.64Dividend Yield2.48%Price Target$31.40 ProfileAnalyst RatingsChartCompetitorsEarningsHeadlinesShort Interest Fresenius SE & Co. KGaA MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside386.1% Upside$31.40 Price TargetShort InterestHealthy0.00% of Shares Sold ShortDividend StrengthModerateBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings Growth19.23%From $0.78 to $0.93 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.94 out of 5 stars 3.3 Analyst's Opinion Consensus RatingFresenius SE & Co. KGaA has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $31.40, Fresenius SE & Co. KGaA has a forecasted upside of 386.1% from its current price of $6.46.Amount of Analyst CoverageFresenius SE & Co. KGaA has only been the subject of 1 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.00% of the outstanding shares of Fresenius SE & Co. KGaA have been sold short.Short Interest Ratio / Days to CoverFresenius SE & Co. KGaA has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Fresenius SE & Co. KGaA has recently increased by 210.42%, indicating that investor sentiment is decreasing significantly. Previous Next 2.5 Dividend Strength Dividend YieldFresenius SE & Co. KGaA pays a meaningful dividend of 2.57%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthFresenius SE & Co. KGaA does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Fresenius SE & Co. KGaA is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 17.20% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for FSNUY. Previous Next 0.6 News and Social Media Coverage News SentimentFresenius SE & Co. KGaA has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Fresenius SE & Co. KGaA this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added Fresenius SE & Co. KGaA to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next N/A Company Ownership Insider Buying vs. Insider SellingIn the past three months, Fresenius SE & Co. KGaA insiders have not sold or bought any company stock. Previous Next 3.8 Earnings and Valuation Earnings GrowthEarnings for Fresenius SE & Co. KGaA are expected to grow by 19.23% in the coming year, from $0.78 to $0.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fresenius SE & Co. KGaA is 9.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 125.45.Price to Earnings Ratio vs. SectorThe P/E ratio of Fresenius SE & Co. KGaA is 9.64, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 152.83.Price to Book Value per Share RatioFresenius SE & Co. KGaA has a P/B Ratio of 0.42. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) StockFresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.Read More Receive FSNUY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address FSNUY Stock News HeadlinesMarch 18, 2023 | reuters.comFREG.DE - | Stock Price & Latest News | ReutersFebruary 22, 2023 | msn.comShares in Fresenius down, FMC up after outlook and reshuffleMarch 27, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.February 22, 2023 | seekingalpha.comFresenius stock rises as Q4 revenue grows, plans restructuring; sees 'headwinds' in FY23February 22, 2023 | msn.comFresenius Medical Care Q4 Profit Slips Despite Higher Revenue, Simplifies StructureFebruary 22, 2023 | bloomberg.comFresenius Slides as Earnings Disappoint, Cloud CEO’s RevampFebruary 22, 2023 | msn.comProfit slips, but revenue rises at German health-care firm FreseniusFebruary 21, 2023 | msn.comEarnings Preview For Fresenius Medical CareMarch 27, 2023 | Oxford Club (Ad)My No. 1 dividend stock for a LIFETIME of income.Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are.February 21, 2023 | finance.yahoo.comUPDATE 2-Fresenius unveils plan to simplify structure, potential profit fallFebruary 10, 2023 | msn.comFresenius considering deconsolidating dialysis subsidiary - BloombergFebruary 9, 2023 | reuters.comFresenius in talks about deconsolidation of FMC - WirtschaftsWocheFebruary 9, 2023 | msn.comFresenius Reviews Potential Sale of Stake in Dialysis UnitJanuary 20, 2023 | msn.comHealthcare workers union petitions FDA to recall Fresenius dialysis machinesJanuary 2, 2023 | finance.yahoo.comFresenius SE KGaA (ETR:FRE) shareholders have endured a 57% loss from investing in the stock five years agoDecember 22, 2022 | marketwatch.comWith 3.3% CAGR, Hemodialysis & Peritoneal Dialysis Market to Witness A Pronounce Growth During 2023-2028 | 104 Pages ReportDecember 16, 2022 | finance.yahoo.comPainful week for individual investors invested in Fresenius SE & Co. KGaA (ETR:FRE) after 3.3% drop, institutions also suffered lossesDecember 6, 2022 | msn.comFMC gets new CEO after parent Fresenius flags business reviewDecember 6, 2022 | msn.comUPDATE 4-FMC boss leaves after two months as Fresenius pushes for changesDecember 5, 2022 | bloomberg.comFresenius Dialysis Unit CEO to Leave Over Strategic DifferencesDecember 2, 2022 | finance.yahoo.comWhy Is Nevro (NVRO) Up 14.9% Since Last Earnings Report?November 29, 2022 | finance.yahoo.comIs Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?November 21, 2022 | theglobeandmail.com$FME : Fresenius Medical Care Enters Monthly Buying AreaNovember 21, 2022 | uk.finance.yahoo.comCOMMERZBANK AG (London Branch) - Pre Stabilisation - Fresenius SE EUR 3.5yr & 7yrNovember 21, 2022 | markets.businessinsider.comEQS-AFR: Fresenius SE & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statementsNovember 9, 2022 | finance.yahoo.comFresenius SE KGaA Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS LagsNovember 8, 2022 | markets.businessinsider.comFresenius Medical Care North America Named Among 100 Healthiest WorkplacesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive FSNUY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Email Address FSNUY Company Calendar Last Earnings2/21/2023Today3/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:FSNUY CUSIPN/A CIKN/A Webwww.fresenius.com Phone(496) 172-6080FaxN/AEmployees316,078Year Founded1912Price Target and Rating Average Stock Price Forecast$31.40 High Stock Price Forecast$46.10 Low Stock Price Forecast$24.00 Forecasted Upside/Downside+398.4%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$0.67 Trailing P/E Ratio9.40 Forward P/E Ratio8.08 P/E GrowthN/ANet Income$1.45 billion Net Margins3.50% Pretax Margin8.74% Return on Equity5.19% Return on Assets2.18% Debt Debt-to-Equity Ratio0.58 Current Ratio1.32 Quick Ratio0.99 Sales & Book Value Annual Sales$43.04 billion Price / Sales0.33 Cash Flow$2.40 per share Price / Cash Flow2.62 Book Value$15.51 per share Price / Book0.41Miscellaneous Outstanding Shares2,234,010,000Free FloatN/AMarket Cap$14.07 billion OptionableNot Optionable Beta1.10 Social Links Key ExecutivesPierluigi AntonelliChief Executive OfficerSara HennickenChief Financial OfficerRice PowellChief Executive Officer-Fresenius Medical CareFrancesco de MeoChief Executive Officer-Fresenius HeliosErnst WastlerChief Executive Officer-Fresenius VamedKey CompetitorsTeleflexNYSE:TFXPenumbraNYSE:PENBaxter InternationalNYSE:BAXShockwave MedicalNASDAQ:SWAVInsuletNASDAQ:PODDView All Competitors FSNUY Stock - Frequently Asked Questions Should I buy or sell Fresenius SE & Co. KGaA stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" FSNUY shares. View FSNUY analyst ratings or view top-rated stocks. What is Fresenius SE & Co. KGaA's stock price forecast for 2023? 9 equities research analysts have issued twelve-month price objectives for Fresenius SE & Co. KGaA's shares. Their FSNUY share price forecasts range from $24.00 to $46.10. On average, they anticipate the company's stock price to reach $31.40 in the next twelve months. This suggests a possible upside of 398.4% from the stock's current price. View analysts price targets for FSNUY or view top-rated stocks among Wall Street analysts. How have FSNUY shares performed in 2023? Fresenius SE & Co. KGaA's stock was trading at $6.99 at the beginning of the year. Since then, FSNUY stock has decreased by 9.9% and is now trading at $6.30. View the best growth stocks for 2023 here. Are investors shorting Fresenius SE & Co. KGaA? Fresenius SE & Co. KGaA saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 14,900 shares, an increase of 210.4% from the February 28th total of 4,800 shares. Based on an average trading volume of 102,200 shares, the days-to-cover ratio is presently 0.1 days. View Fresenius SE & Co. KGaA's Short Interest. How were Fresenius SE & Co. KGaA's earnings last quarter? Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) announced its earnings results on Tuesday, February, 21st. The company reported $0.20 earnings per share for the quarter. The firm earned $10.87 billion during the quarter. Fresenius SE & Co. KGaA had a net margin of 3.50% and a trailing twelve-month return on equity of 5.19%. Is Fresenius SE & Co. KGaA a good dividend stock? Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) pays an annual dividend of $0.16 per share and currently has a dividend yield of 2.57%. The dividend payout ratio is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FSNUY will have a dividend payout ratio of 17.20% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for FSNUY. What is Fresenius SE & Co. KGaA's stock symbol? Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY." How do I buy shares of Fresenius SE & Co. KGaA? Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Fresenius SE & Co. KGaA's stock price today? One share of FSNUY stock can currently be purchased for approximately $6.30. How much money does Fresenius SE & Co. KGaA make? Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) has a market capitalization of $14.07 billion and generates $43.04 billion in revenue each year. The company earns $1.45 billion in net income (profit) each year or $0.67 on an earnings per share basis. How many employees does Fresenius SE & Co. KGaA have? The company employs 316,078 workers across the globe. How can I contact Fresenius SE & Co. KGaA? Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The official website for the company is www.fresenius.com. The company can be reached via phone at (496) 172-6080 or via email at ir-fre@fresenius.com. This page (OTCMKTS:FSNUY) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.